Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 2 minute read Pharma Industry News Incyte’s Ruxolitinib Cream demonstrates promising efficacy in TRuE-AD3 study Incyte (Nasdaq:INCY), an esteemed biopharmaceutical giant, has unveiled compelling expanded findings from its Phase 3 TRuE-AD3 study on… byPallavi MadhirajuOctober 15, 2023